Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Canopy Growth Corporation - Common Shares
(NQ:
CGC
)
0.6515
-0.0242 (-3.58%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Canopy Growth Corporation - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors
↗
Today 11:20 EST
Canopy's EU GMP certification spans its entire supply chain, so it can sell into Europe without relying on third parties.
Via
The Motley Fool
Topics
Cannabis
Earnings
Economy
Canopy Growth (CGC) Q2 2027 Earnings Call Transcript
↗
November 06, 2026
Margins slipped as Canadian medical reimbursement fell, even as revenue climbed.
Via
The Motley Fool
Topics
Cannabis
Earnings
Canopy Growth Q2 Earnings Call Highlights
↗
November 06, 2026
Canopy Growth (NASDAQ:CGC) reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve...
Via
MarketBeat
Topics
Cannabis
Earnings
Cannabis Stocks Are Splitting Into Profitable Leaders and Sentiment-Driven Laggards
↗
November 05, 2026
Via
Chartmill
Topics
Cannabis
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
↗
October 30, 2026
Tilray commands a 4x revenue advantage, but Canopy's latest quarter hints at momentum—here's what the data reveals about their competitive positioning.
Via
The Motley Fool
Topics
Cannabis
Economy
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
↗
October 23, 2026
Canopy Growth (NASDAQ:CGC) shareholders approved all matters presented at the company’s reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election...
Via
MarketBeat
Topics
Cannabis
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
↗
October 18, 2026
Larger issues loom at home for the Canada-based cannabis company.
Via
The Motley Fool
Topics
Cannabis
Government
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
↗
October 15, 2026
The cannabis industry is still finding its footing, but Tilray just posted record revenue with its beverage business turning profitable. Canopy is narrowing losses and targeting positive EBITDA by...
Via
The Motley Fool
Topics
Cannabis
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
↗
October 10, 2026
Canopy pursues a lean U.S.-focused strategy while Tilray has diversified into beverages, but their diverging paths and financial profiles reveal starkly different risk-reward profiles for 2026.
Via
The Motley Fool
Topics
Cannabis
Can Canopy Growth Survive Another 5 Years?
↗
October 06, 2026
The company is still burning through cash, and its outlook doesn't look all that great.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock?
↗
September 30, 2026
Improving fundamentals are making Canopy harder to ignore.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?
↗
September 23, 2026
Canopy Growth's stock has continued to fall, prompting the company to proactively seek to retain access to capital markets.
Via
The Motley Fool
Topics
Bonds
Cannabis
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?
↗
September 14, 2026
Two long-standing issues continue to weigh on this cannabis stock.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why.
↗
September 07, 2026
Revenue is growing, but the cannabis company still has a lot to prove to investors.
Via
The Motley Fool
Topics
Cannabis
Should You Buy Canopy Growth Stock on the Rebound?
↗
September 05, 2026
Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment?
Via
The Motley Fool
Topics
Cannabis
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?
↗
September 02, 2026
The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now.
Via
The Motley Fool
Topics
Cannabis
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.
↗
August 21, 2026
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.
Via
The Motley Fool
Topics
Cannabis
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?
↗
August 16, 2026
Cannabis consolidation appears to be accelerating.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth (CGC) Q1 2027 Earnings Call Transcript
↗
August 14, 2026
Revenue grew 13% as MTL integration and Polish market strength drove results.
Via
The Motley Fool
Topics
Cannabis
Earnings
World Trade
Will Canopy Growth Get Acquired?
↗
August 13, 2026
Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts
↗
August 12, 2026
Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and...
Via
MarketBeat
Topics
Cannabis
Economy
Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making?
↗
August 11, 2026
The turnaround is becoming more believable.
Via
The Motley Fool
Topics
Cannabis
Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think
↗
August 08, 2026
Canopy Growth is a marijuana stock, but U.S. regulations aren't the main driver of its business.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth Q1 Earnings Call Highlights
↗
August 07, 2026
Canopy Growth (NASDAQ:CGC) reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and...
Via
MarketBeat
Topics
Cannabis
Earnings
Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First.
↗
July 25, 2026
The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency.
Via
The Motley Fool
Topics
Cannabis
Economy
Government
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
↗
July 17, 2026
The president directed federal authorities to reschedule medical marijuana.
Via
The Motley Fool
Topics
Cannabis
Government
Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?
↗
July 08, 2026
A lower stock price doesn't eliminate investment risk.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth: Is Another Reverse Stock Split Inevitable?
↗
July 07, 2026
Shares of the cannabis company have fallen below the $1 mark again.
Via
The Motley Fool
Topics
Cannabis
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.
↗
July 04, 2026
Be careful before bucking the bearish trend.
Via
The Motley Fool
Topics
Cannabis
Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound?
↗
June 28, 2026
Canopy Growth's medical marijuana division had a great quarter, but the rest of the business wasn't so lucky.
Via
The Motley Fool
Topics
Cannabis
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today